Kythera Biopharmaceuticals' Grant - II Round

Kythera Biopharmaceuticals raised a round of funding on December 28, 2010. Investors include Qualifying Therapeutic Discovery Project.

Kythera (NASDAQ: KYTH) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. The C…

Articles about Kythera Biopharmaceuticals' Grant - II Round: